These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2375555)

  • 1. Labetalol hepatotoxicity.
    Clark JA; Zimmerman HJ; Tanner LA
    Ann Intern Med; 1990 Aug; 113(3):210-3. PubMed ID: 2375555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Labetalol-induced hepatitis in a patient with chronic hepatitis B infection.
    Marinella MA
    J Clin Hypertens (Greenwich); 2002; 4(2):120-1. PubMed ID: 11927791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal labetalol-induced hepatic injury.
    Douglas DD; Yang RD; Jensen P; Thiele DL
    Am J Med; 1989 Aug; 87(2):235-6. PubMed ID: 2757062
    [No Abstract]   [Full Text] [Related]  

  • 4. Fatal hepatotoxicity induced by hydralazine or labetalol.
    Stumpf JL
    Pharmacotherapy; 1991; 11(5):415-8. PubMed ID: 1745625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Toxic hepatocellular hepatitis due to labetalol].
    Castiella A; Iglesias U; Zapata E; Zubiaurre L; Iribarren A
    Gastroenterol Hepatol; 2015 May; 38(5):326-7. PubMed ID: 25073680
    [No Abstract]   [Full Text] [Related]  

  • 6. A case of labetalol-induced hepatitis.
    Stronkhorst A; Bosma A; van Leeuwen DJ
    Neth J Med; 1992 Apr; 40(3-4):200-2. PubMed ID: 1603212
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatocellular necrosis associated with labetalol.
    Long RC; Wofford MR; Harkins KG; Minor DS
    J Clin Hypertens (Greenwich); 2007 Apr; 9(4):287-90. PubMed ID: 17396073
    [No Abstract]   [Full Text] [Related]  

  • 8. [Histological changes in viral hepatitis].
    Aguirre-García J; Ramos-Martínez E; Velasco-Avilés F
    Rev Gastroenterol Mex; 1982; 47(3):139-48. PubMed ID: 6085520
    [No Abstract]   [Full Text] [Related]  

  • 9. Labetalol hepatotoxicity.
    Ann Intern Med; 1991 Feb; 114(4):341. PubMed ID: 2018583
    [No Abstract]   [Full Text] [Related]  

  • 10. Labetalol hepatotoxicity.
    Thiele DL
    Am J Med; 1989 Sep; 87(3):361. PubMed ID: 2773977
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatic injury associated with diphenylhydantoin therapy. A clinicopathologic study of 20 cases.
    Mullick FG; Ishak KG
    Am J Clin Pathol; 1980 Oct; 74(4):442-52. PubMed ID: 7424826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal and nonfatal hepatotoxicity associated with flutamide.
    Wysowski DK; Freiman JP; Tourtelot JB; Horton ML
    Ann Intern Med; 1993 Jun; 118(11):860-4. PubMed ID: 7683180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ticrynafen-associated hepatic injury: analysis of 340 cases.
    Zimmerman HJ; Lewis JH; Ishak KG; Maddrey WC
    Hepatology; 1984; 4(2):315-23. PubMed ID: 6706306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic histopathology and clinical characteristics associated with antiretroviral therapy in HIV patients without viral hepatitis.
    Akhtar MA; Mathieson K; Arey B; Post J; Prevette R; Hillier A; Patel P; Ram LJ; Van Thiel DH; Nadir A
    Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1194-204. PubMed ID: 18989143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis of toxic and drug-induced hepatocellular damage in patients treated in viral hepatitis units].
    Tolwińska I
    Pol Tyg Lek; 1977 Sep; 32(37):1425-8. PubMed ID: 905188
    [No Abstract]   [Full Text] [Related]  

  • 16. Imatinib mesylate-induced hepato-toxicity in chronic myeloid leukemia demonstrated focal necrosis resembling acute viral hepatitis.
    Ohyashiki K; Kuriyama Y; Nakajima A; Tauchi T; Ito Y; Miyazawa H; Kimura Y; Serizawa H; Ebihara Y
    Leukemia; 2002 Oct; 16(10):2160-1. PubMed ID: 12357373
    [No Abstract]   [Full Text] [Related]  

  • 17. [Toxic liver injuries].
    Krähenbühl S
    Ther Umsch; 2004 Aug; 61(8):529-34. PubMed ID: 15457970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketoconazole-induced liver damage.
    Findor JA; Sorda JA; Igartua EB; Avagnina A
    Medicina (B Aires); 1998; 58(3):277-81. PubMed ID: 9713096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differential diagnosis of alcholic and viral affections of the liver].
    Mukhin AS; Semendiaeva ME; Blinkov IL; Vinogradova LG
    Sov Med; 1977 May; (5):7-13. PubMed ID: 877751
    [No Abstract]   [Full Text] [Related]  

  • 20. Labetalol-induced toxic myopathy.
    Teicher A; Rosenthal T; Kissin E; Sarova I
    Br Med J (Clin Res Ed); 1981 Jun; 282(6279):1824-5. PubMed ID: 6786636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.